Followers | 29 |
Posts | 6477 |
Boards Moderated | 0 |
Alias Born | 05/17/2011 |
Thursday, April 19, 2018 3:12:05 PM
Recent RGNX News
- REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference • PR Newswire (US) • 09/23/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:04:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:03:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:00:23 PM
- REGENXBIO Appoints Mitchell Chan as Chief Financial Officer • PR Newswire (US) • 09/17/2024 11:05:00 AM
- REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect • PR Newswire (US) • 09/03/2024 12:04:00 PM
- REGENXBIO to Participate in Upcoming Investor Conferences • PR Newswire (US) • 08/29/2024 08:05:00 PM
- REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium • PR Newswire (US) • 08/27/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 08:58:45 PM
- REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • PR Newswire (US) • 08/08/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:41:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:38:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:10 PM
- REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 08/01/2024 08:05:00 PM
- REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 • PR Newswire (US) • 08/01/2024 11:03:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 09:00:10 PM
- REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 07/25/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 09:05:11 PM
- REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients • PR Newswire (US) • 06/24/2024 11:05:00 AM
- REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX-121 for the Treatment of MPS II • PR Newswire (US) • 06/18/2024 11:05:00 AM
- REGENXBIO Announces Leadership Transition • PR Newswire (US) • 06/12/2024 11:05:00 AM
- REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/05/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:43:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:42:20 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM